Studies have shown that plasma Angiopoietin-2 increases after Non-small cell lung cancer (NSCLC) surgery and contributes to the proangiogenic property of the postoperative plasmas. This evidence concerns the gene ANGPT2 and non-small cell lung carcinoma.